Amplification of USP13 drives ovarian cancer metabolism.
about
Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors.Ubiquitination and deubiquitination emerge as players in idiopathic pulmonary fibrosis pathogenesis and treatment.Inhibition of Ubiquitin-Specific Proteases as a Novel Anticancer Therapeutic StrategyHeterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II
P2860
Amplification of USP13 drives ovarian cancer metabolism.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Amplification of USP13 drives ovarian cancer metabolism.
@en
Amplification of USP13 drives ovarian cancer metabolism.
@nl
type
label
Amplification of USP13 drives ovarian cancer metabolism.
@en
Amplification of USP13 drives ovarian cancer metabolism.
@nl
prefLabel
Amplification of USP13 drives ovarian cancer metabolism.
@en
Amplification of USP13 drives ovarian cancer metabolism.
@nl
P2093
P2860
P50
P356
P1476
Amplification of USP13 drives ovarian cancer metabolism.
@en
P2093
Cheng Huang
Hyun Ho Choi
Joelle Baddour
Lifeng Yang
Xinna Zhang
Xiongbin Lu
Yunhua Liu
P2860
P2888
P356
10.1038/NCOMMS13525
P407
P577
2016-11-28T00:00:00Z
P6179
1053287748